Suppr超能文献

种间和种内性别差异对 K-肟类候选药物急性毒性的影响。

Interspecies and intergender differences in acute toxicity of K-oximes drug candidates.

机构信息

National Poison Control Centre, Military Medical Academy, 17 Crnotravska St, 11000, Belgrade, Republic of Serbia; Medical Faculty of the Military Medical Academy, University of Defence, 1 Pavla Jurišića-Šturma St, 11000, Belgrade, Republic of Serbia; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanského 62, 50003, Hradec Králové, Czech Republic.

Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanského 62, 50003, Hradec Králové, Czech Republic.

出版信息

Chem Biol Interact. 2019 Aug 1;308:312-316. doi: 10.1016/j.cbi.2019.05.035. Epub 2019 May 31.

Abstract

K-oximes were developed as modern drug candidates acting as AChE reactivators. In this study, it has been investigated which interspecies and intergender differences changes could be observed in Wistar rats and Swiss mice, both genders, after the treatment with increasing doses of selected acetylcholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. After the 24 h, a number of died animals was counted and the median lethal dose (LD) for each oxime was calculated. By using the intramuscular route of administration, asoxime and K027 had the least toxicity in female rats (640.21 mg/kg and 686.08 mg/kg), and in female mice (565.75 mg/kg and 565.74 mg/kg), respectively. Moreover, asoxime and K027 showed 3, 4 or 8 times less acute toxicity in comparison to K048, obidoxime and K075, respectively. Beyond, K075 had the greatest toxicity in male rats (81.53 mg/kg), and in male mice (57.34 mg/kg), respectively. Our results can help to predict likely adverse toxic effects, target organ systems and possible outcome in the event of massive human overexposure, and in establishing risk categories or in dose selection for the initial repeated dose toxicity tests to be conducted for each oxime.

摘要

K-肟类化合物已被开发为作用于乙酰胆碱酯酶重激活剂的现代药物候选物。在这项研究中,研究了在 Wistar 大鼠和瑞士小鼠中,在接受递增剂量的选定乙酰胆碱酯酶重激活剂 - asoxime、obidoxime、K027、K048 和 K075 治疗后,哪些种间和性别差异会发生变化。24 小时后,计算了死亡动物的数量,并计算了每种肟的半数致死剂量(LD)。通过肌肉内给药途径,asoxime 和 K027 在雌性大鼠(640.21mg/kg 和 686.08mg/kg)和雌性小鼠(565.75mg/kg 和 565.74mg/kg)中的毒性最小。此外,与 K048、obidoxime 和 K075 相比,asoxime 和 K027 的急性毒性分别低 3、4 或 8 倍。此外,K075 在雄性大鼠(81.53mg/kg)和雄性小鼠(57.34mg/kg)中的毒性最大。我们的结果有助于预测大量人体暴露时可能发生的不良毒性作用、靶器官系统和可能的结果,并有助于为每个肟类化合物建立风险类别或剂量选择,以进行初始重复剂量毒性试验。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验